anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Exercise training for adults undergoing maintenance dialysis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Renal Dialysis
Provide patient population that should be included in the study
Calcium supplementation for prevention of primary hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Normal Blood Pressure 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
High versus low‐added sugar consumption for the primary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Malnutrition 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Effect of periodontal treatments on blood pressure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Periodontitis 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Hypertensive disorder
Provide patient population that should be included in the study
Mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Roselle for hypertension in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Hypertensive disorder 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Omega‐3 fatty acids for depression in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Major depressive disorder 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Humour‐based interventions for people with schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenia 6. Aged 65-79 years
Provide patient population that should be included in the study
Palliative care interventions in advanced dementia
1. Dementia
Provide patient population that should be included in the study
Cannabinoids for the treatment of dementia
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Aged 65-79 years 4. Dementia
Provide patient population that should be included in the study
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
1. Adult 19-44 years 2. Subfertility 3. Young Adult 19-24 years 4. Polycystic Ovarian Syndrome 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Ginseng for erectile dysfunction
1. Aged 80 and over 80+ years 2. Erectile Dysfunction 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Probiotics for preventing gestational diabetes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Coronary Heart Disease 5. Young Adult 19-24 years 6. Cardiovascular Event Risk 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Coenzyme Q10 for heart failure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Heart Failure 6. Aged 65-79 years
Provide patient population that should be included in the study
Intermittent fasting for the prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Souvenaid for Alzheimer's disease
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Alzheimer's Disease 4. Mild Cognitive Impairment 5. Aged 65-79 years
Provide patient population that should be included in the study
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Normal Blood Pressure 6. Essential Hypertension 7. Elevated Blood Pressure 8. Aged 65-79 years
Provide patient population that should be included in the study
Acupuncture for chronic nonspecific low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Melatonin for preoperative and postoperative anxiety in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Administration Of Anesthesia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Iron chelators for acute stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hemorrhagic Cerebral Infarction 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacotherapies for sleep disturbances in dementia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Sleep Problem 6. Aged 65-79 years 7. Dementia
Provide patient population that should be included in the study
Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Phlebotonics for venous insufficiency
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Venous insufficiency 6. Aged 65-79 years
Provide patient population that should be included in the study
Low protein diets for non‐diabetic adults with chronic kidney disease
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Chronic Kidney Disease
Provide patient population that should be included in the study
Magnesium for skeletal muscle cramps
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Leg Cramps 6. Skeletal Muscle Problem 7. Physical Exercises 8. Aged 65-79 years 9. Adolescent 13-18 years 10. Adult 19-44 years 11. Nocturnal Muscle Cramp 12. Middle Aged 45-64 years 13. Young Adult 19-24 years 14. Pregnancy 15. Muscle Cramp 16. Birth to 1 mo
Provide patient population that should be included in the study
Antioxidants for female subfertility
1. Adult 19-44 years 2. Subfertility 3. Young Adult 19-24 years
Provide patient population that should be included in the study
Reduction in saturated fat intake for cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular Event Risk 6. Aged 65-79 years
Provide patient population that should be included in the study
Aromatherapy for dementia
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Aged 65-79 years 4. Dementia
Provide patient population that should be included in the study
Therapeutic ultrasound for chronic low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Tea tree oil for Demodex blepharitis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Demodectic Blepharitis 6. Aged 65-79 years
Provide patient population that should be included in the study
Dietary interventions for multiple sclerosis‐related outcomes
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Chelation therapy for atherosclerotic cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Arteriosclerotic Vascular Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Probiotics for induction of remission in ulcerative colitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Ulcerative Colitis 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular Event Risk 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Multiple chronic conditions
Provide patient population that should be included in the study
Electrical stimulation for treating pressure ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Pressure ulcer 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Omega‐3 and omega‐6 polyunsaturated fatty acids for dry eye disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Keratoconjunctivitis Sicca 4. Sjogren's syndrome 5. Middle Aged 45-64 years 6. Dry Eyes 7. Young Adult 19-24 years 8. Ocular Surface Disease 9. Aged 65-79 years
Provide patient population that should be included in the study
Psychosocial interventions for preventing and treating depression in dialysis patients
1. Adult 19-44 years 2. End Stage Kidney Disease 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Depression 6. Adolescent 13-18 years 7. Renal Dialysis
Provide patient population that should be included in the study
Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis
1. Adult 19-44 years 2. Ileoanal Anastomosis 3. Middle Aged 45-64 years 4. Chronic Ulcerative Colitis 5. Young Adult 19-24 years 6. Pouchitis 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Animal‐assisted therapy for dementia
1. Not reported 2. Dementia
Provide patient population that should be included in the study
Biofeedback for treatment of irritable bowel syndrome
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Irritable bowel syndrome 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Chronic Type B Viral Hepatitis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for pityriasis rosea
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Pityriasis Rosea 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for chronic hepatitis B
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Chronic hepatitis B 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for polycystic ovarian syndrome
1. Adult 19-44 years 2. Anovulation 3. Young Adult 19-24 years 4. Polycystic Ovarian Syndrome 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Melatonin and agomelatine for preventing seasonal affective disorder
1. Adult 19-44 years 2. Seasonal Affective Disorder 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Diabetic Neuropathy
Provide patient population that should be included in the study
Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aphasia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga as part of a package of care versus non‐standard care for schizophrenia
1. Schizophrenic Related Disorders 2. Schizophrenia
Provide patient population that should be included in the study
Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Chronic hepatitis B 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Herbal medicinal products or preparations for neuropathic pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Light therapy for preventing seasonal affective disorder
1. Adult 19-44 years 2. Seasonal Affective Disorder 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. At Risk Of Disease 6. Aged 65-79 years 7. Healthy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga for treating urinary incontinence in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Stress urinary incontinence 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Urge Incontinence
Provide patient population that should be included in the study
Exercise for preventing falls in older people living in the community
1. Aged 80 and over 80+ years 2. At Risk For Falls 3. Aged 65-79 years
Provide patient population that should be included in the study
Iron for the treatment of restless legs syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Restless Legs Syndrome 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Meniere's Disease 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Single herbal medicine for diabetic retinopathy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Diabetic Retinopathy
Provide patient population that should be included in the study
Acupuncture for symptomatic gastroparesis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Gastroparesis Syndrome 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Normal Cognition 6. Aged 65-79 years
Provide patient population that should be included in the study
Traditional Chinese herbal medicine for vascular dementia
1. Vascular Dementia
Provide patient population that should be included in the study
Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Carpal Tunnel Syndrome
Provide patient population that should be included in the study
Omega‐6 fats for the primary and secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. At Risk Of Disease 6. Aged 65-79 years 7. Healthy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. At Risk Of Disease 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for hypertension
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Essential Hypertension 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Cannabis for the treatment of Crohn's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Crohn's Disease 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Rutosides for prevention of post‐thrombotic syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Deep Venous Thrombosis
Provide patient population that should be included in the study
Rutosides for treatment of post‐thrombotic syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Post-thrombotic syndrome 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Mild Cognitive Impairment
Provide patient population that should be included in the study
Non‐clinical interventions for reducing unnecessary caesarean section
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Healthcare Professional 7. Young Adult 19-24 years 8. Pregnancy 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin D for the management of multiple sclerosis
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Art therapy for people with dementia
1. Dementia
Provide patient population that should be included in the study
Interventions for preventing falls in older people in care facilities and hospitals
1. Aged 80 and over 80+ years 2. At Risk For Falls 3. Hospitalism 4. Aged 65-79 years 5. Living In Nursing Home
Provide patient population that should be included in the study
Mindfulness‐based stress reduction for family carers of people with dementia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Caregiver 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Dementia
Provide patient population that should be included in the study
Music‐based therapeutic interventions for people with dementia
1. Dementia
Provide patient population that should be included in the study
Prescribed hypocaloric nutrition support for critically‐ill adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Immersion in water during labour and birth
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Normal Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐invasive brain stimulation techniques for chronic pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Chronic Pain
Provide patient population that should be included in the study
Acupuncture for acute stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Relaxation techniques for pain management in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Massage, reflexology and other manual methods for pain management in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Vitamin B Deficiency 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Aromatherapy for treatment of postoperative nausea and vomiting
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Local Anesthesia 6. Sedated 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Surgery 12. Young Adult 19-24 years 13. Birth to 1 mo 14. General Anesthesia
Provide patient population that should be included in the study
Acupuncture for depression
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Depression 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates
1. Birth to 1 mo 2. Preterm Infant
Provide patient population that should be included in the study
Vitamin E for antipsychotic‐induced tardive dyskinesia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Mental Disorder 6. Schizophrenia 7. Tardive dyskinesia 8. Aged 65-79 years
Provide patient population that should be included in the study
Respiratory muscle training for multiple sclerosis
1. Aged 80 and over 80+ years 2. Multiple Sclerosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Clostridium Difficile Infection 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidants for preventing and reducing muscle soreness after exercise
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Muscular Pain 8. Physical Exercises 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Probiotics for vulvovaginal candidiasis in non‐pregnant women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Not Pregnant 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Vulvovaginal Candidiasis 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Music therapy for depression
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Depression 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Combined diet and exercise interventions for preventing gestational diabetes mellitus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture or acupressure for induction of labour
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga for epilepsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Epilepsy 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga as part of a package of care versus standard care for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Yoga versus non‐standard care for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological and mechanical interventions for labour induction in outpatient settings
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Viable Fetus 5. Third Trimester Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin A supplements for reducing mother‐to‐child HIV transmission
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Breast Fed 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Whole grain cereals for the primary or secondary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Homocysteine‐lowering interventions for preventing cardiovascular events
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Low glycaemic index diets for the prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Aged 65-79 years 4. Healthy
Provide patient population that should be included in the study
Deep brain and cortical stimulation for epilepsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Generalized Seizure 8. Adult 19-44 years 9. Partial Seizure 10. Middle Aged 45-64 years 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Refractory Epilepsy
Provide patient population that should be included in the study
Continuous support for women during childbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Normal Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Wendan decoction (Traditional Chinese medicine) for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Music therapy for people with schizophrenia and schizophrenia‐like disorders
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Branched‐chain amino acids for people with hepatic encephalopathy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Hepatic Encephalopathy 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Therapeutic ultrasound for venous leg ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Venous leg ulcer 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Effect of cocoa on blood pressure
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Vitamin E for Alzheimer's dementia and mild cognitive impairment
1. Mild Cognitive Impairment 2. Dementia Due To Alzheimer's Disease
Provide patient population that should be included in the study
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
1. Birth to 1 mo 2. Preterm Infant
Provide patient population that should be included in the study
L‐carnitine for cognitive enhancement in people without cognitive impairment
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Normal Cognition 6. Aged 65-79 years
Provide patient population that should be included in the study
Calcium and phosphorus supplementation of human milk for preterm infants
1. Birth to 1 mo 2. Hospitalization 3. Preterm Infant
Provide patient population that should be included in the study
Different types of dietary advice for women with gestational diabetes mellitus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Gestational Diabetes Mellitus 6. Diabetes Mellitus 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Probiotics for people with hepatic encephalopathy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Chronic Liver Disease 5. Infant 1 to 23 mo 6. Hepatic Encephalopathy 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Toxic Acute Liver Disease 10. Adult 19-44 years 11. Middle Aged 45-64 years 12. Young Adult 19-24 years 13. Birth to 1 mo 14. Acute Hepatic Failure
Provide patient population that should be included in the study
Acupuncture for acute hordeolum
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Hordeolum 4. Middle Aged 45-64 years 5. Infant 1 to 23 mo 6. Internal Hordeolum 7. Young Adult 19-24 years 8. Aged 65-79 years
Provide patient population that should be included in the study
Music interventions for acquired brain injury
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Acquired Brain Injury 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Neuropathic Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Longchain polyunsaturated fatty acid supplementation in preterm infants
1. Enteral nutrition 2. Birth to 1 mo 3. Preterm Infant
Provide patient population that should be included in the study
Nutrient‐enriched formula versus standard formula for preterm infants following hospital discharge
1. Hospital discharge 2. Partially hydrolysed infant formula 3. Birth to 1 mo 4. Preterm Infant
Provide patient population that should be included in the study
Electrical stimulation with non‐implanted electrodes for overactive bladder in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Overactive Bladder Syndrome 6. Mixed Incontinence 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Urge Incontinence
Provide patient population that should be included in the study
Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo
Provide patient population that should be included in the study
Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Acute Respiratory Tract Infection 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Nutritional supplementation for hip fracture aftercare in older people
1. Aged 80 and over 80+ years 2. Hip Fracture 3. Aged 65-79 years
Provide patient population that should be included in the study
Zinc supplementation for tinnitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Tinnitus 6. Aged 65-79 years
Provide patient population that should be included in the study
Transcutaneous electrical stimulation (TES) for treatment of constipation in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Incontinence 6. Constipation 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin D supplementation for preventing infections in children under five years of age
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Birth to 1 mo
Provide patient population that should be included in the study
Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Autism Spectrum Disorder 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods of milk expression for lactating women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Lactating Breast 4. Young Adult 19-24 years 5. Expression Of Breast Milk 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
1. Middle Income 2. Infant 1 to 23 mo 3. Breast Fed 4. Low Income
Provide patient population that should be included in the study
Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Learning Disorder 4. Developmental Reading Disorder 5. Dyscalculia 6. Specific Spelling Disorder 7. Adolescent 13-18 years 8. Dysgraphia
Provide patient population that should be included in the study
Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Measles 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for stroke rehabilitation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hemorrhagic Cerebral Infarction 5. Young Adult 19-24 years 6. Ischemic Stroke 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
1. Birth to 1 mo 2. Low Birth Weight Infant
Provide patient population that should be included in the study
Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants
1. Very Preterm Infant (28-31 weeks) 2. Extremely Preterm Infant (<28 weeks) 3. Birth to 1 mo 4. Extremely Low Birth Weight Infant 5. Very Low Birth Weight Infant
Provide patient population that should be included in the study
Fish oil for kidney transplant recipients
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Calcineurin inhibitor 6. Kidney transplant 7. Young Adult 19-24 years 8. Immunosuppressive Therapy For Transplant 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Drug Resistant Epilepsy 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Cycled light in the intensive care unit for preterm and low birth weight infants
1. Birth to 1 mo 2. Low Birth Weight Infant 3. Intensive Care 4. Preterm Infant
Provide patient population that should be included in the study
Xylitol for preventing acute otitis media in children up to 12 years of age
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo
Provide patient population that should be included in the study
Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Idiopathic Parkinsonism 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Nutritional supplements for people being treated for active tuberculosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. HIV viraemia 6. Middle Aged 45-64 years 7. Tuberculosis 8. Infant 1 to 23 mo 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture and related interventions for symptoms of chronic kidney disease
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Chronic Kidney Disease 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for the prevention of episodic migraine
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Migraine 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Tai Chi for chronic obstructive pulmonary disease (COPD)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Obstructive Pulmonary Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Hypnosis for pain management during labour and childbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin supplementation for preventing miscarriage
1. Adult 19-44 years 2. First Trimester Pregnancy 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Young Adult 19-24 years 6. Pregnancy 7. Trying To Conceive 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga for asthma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Asthma
Provide patient population that should be included in the study
Acupuncture for the prevention of tension‐type headache
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Chronic Tension-type Headache 5. Young Adult 19-24 years 6. Episodic Tension-type Headache 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Glutamine supplementation to prevent morbidity and mortality in preterm infants
1. Term infant (37-41 weeks) 2. Birth to 1 mo 3. Intensive Care 4. Preterm Infant
Provide patient population that should be included in the study
Omega‐3 fatty acids for the treatment of dementia
1. Aged 80 and over 80+ years 2. Aged 65-79 years 3. Dementia
Provide patient population that should be included in the study
Padma 28 for intermittent claudication
1. Intermittent claudication
Provide patient population that should be included in the study
Melatonin for women in pregnancy for neuroprotection of the fetus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin A supplementation for postpartum women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Dietary advice for people with schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenia 6. Schizophrenic Psychoses 7. Aged 65-79 years
Provide patient population that should be included in the study
Dietary supplements for dysmenorrhoea
1. Adult 19-44 years 2. Primary Dysmenorrhea 3. Young Adult 19-24 years 4. Secondary Dysmenorrhea 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Serum Creatinine Increased 7. Young Adult 19-24 years 8. Essential Hypertension 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Puerarin for ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidant treatments for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenia And Other Psychotic Disorders 6. Schizophrenia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese herbal medicines for unexplained recurrent miscarriage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Recurrent Miscarriage 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Cluster Headache 8. Migraine 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for central serous chorioretinopathy: a network meta‐analysis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Central Serous Chorioretinopathy 6. Aged 65-79 years
Provide patient population that should be included in the study
Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Surgery 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Ozone therapy for treating foot ulcers in people with diabetes
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Type 2 Diabetes Mellitus 5. Young Adult 19-24 years 6. Diabetic Foot Ulcer 7. Type 1 Diabetes Mellitus 8. Aged 65-79 years